Ackermans & van Haaren: Record result from core segment, in line with estimate. Bekaert: In-line 2024, 2025F guidance suggests weak 1H25 momentum. Belgian telecoms: Management/liquidity crisis at DIGI Belgium. bpost: 4Q24 beats but no dividend over FY24, FY25 outlook well below. Elia: Preview FY24, capex and financing in focus. Fugro: After a nice beat, moving into FY25 dynamics. Kendrion: No recovery signals. Proximus: Neutral 4Q24, 2025 guidance. Recticel: UK Deputy PM calls fo...
Two Directors at Kendrion N.V. bought 8,100 shares at between 10.768EUR and 10.770EUR. The significance rating of the trade was 50/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the l...
>Q3 results mixed to positive - The Q3 results were mixed to positive. Industrial did better than expected in terms of sales (growth in IB and flat in IAC) but the Residual automotive part was impacted by a negative development in Sound and Fuel controllers with good but not great growth in Automotive China. Positive was that the EBITDA margin came in materially higher than anticipated (12.1% vs 10.5%). In the analyst call CEO van Beurden indicated that some projects ...
>Sales a miss (Auto related), Industrial sales a beat, EBITDA margins a beat - Kendrion Q3 sales missed our estimates (no css) by 4%, which is solely driven by the Residual automotive business as IAC and Industral Brakes performed well. Due to cost savings and higher sales levels, the adj. EBITDA came in at €8.8m or a beat of 12% with the adj. EBITDA margin coming in at 12.1% versus our expectation of 10.5%. Due to that better than expected performance, the net profit...
Ahold Delhaize: A strong 3Q24, driven by Europe. CFE: 3Q24 preview - able to keep net profit outlook? CTP: Good results, guidance reiterated. DEME Group: 3Q24 preview - keeping the FY outlook. Exor: Ferrari hitting Chinese wall. IBA: Contract win for E-beam sterilisation solution in the Dominican Republic. Kendrion: 3Q24 preview - harsh end markets but easy comps. Proximus: 2025 price increases on the high side, more asset sales in the pipeline. Solvay: 3Q24 results beat by 4% bu...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.